Results 171 to 180 of about 49,427 (236)

Preclinical efficacy of tasquinimod-based combinations in advanced myeloproliferative neoplasms in blastic phase. [PDF]

Blood Adv
Fiskus W, Masarova L, Mill CP, Birdwell CE, Das K, Hou H, Davis JA, Jain A, Malovannaya A, Manshouri T, Dunbar A, Sharma S, Kadia TM, DiNardo CD, Bose P, Pemmaraju N, Loghavi S, Su X, Rampal RK, Törngren M, Bhalla KN.   +20 more
europepmc   +1 more source

Clinical impact of atrial fibrillation on hospitalized patients with myeloproliferative neoplasms: A nationwide analysis [PDF]

Samhitha Gundakaram, Leen Kayali, Leena Alhusari, Madho Mal, Muhammad Jamil   +4 more
openalex   +1 more source

Spleen in myeloproliferative neoplasms

HemaSphere, 2018
Giovanni Barosi
doaj   +1 more source

Second malignancies among older patients with classical myeloproliferative neoplasms treated with ruxolitinib. [PDF]

Blood Neoplasia
Wang R, Stempel JM, Shallis RM, Huntington SF, Zeidan AM, Neparidze N, Di M, Bewersdorf JP, Mendez L, Ma X, Podoltsev NA.   +10 more
europepmc   +1 more source

Health Distress and Challenges in Patients With Myeloproliferative Neoplasms During Follow-Up Consultations at the Outpatient Clinic: A Phenomenological Study. [PDF]

Cancer Rep (Hoboken)
Liu Y, Zhao J, Zhang Q, Gao Q, Cao Y, He J, Han L, Wang Y, Yang Q, Xie W.   +9 more
europepmc   +1 more source

QRISK3 score is predictive of thrombotic risk in patients with myeloproliferative neoplasms. [PDF]

Leukemia
Duminuco A, Vaghela R, Virdee S, Woodley C, Asirvatham S, Curto-Garcia N, Sriskandarajah P, O'Sullivan J, de Lavallade H, Radia D, Kordasti S, Palumbo GA, Harrison C, Harrington P.   +13 more
europepmc   +1 more source

JAK2 46/1 (GGCC) Haplotype in Oncogenesis, as Risk Stratifier, and Indicator for Drug Resistance in Myeloproliferative Neoplasms. [PDF]

Int J Mol Sci
Perrone M, Sergio S, Pranzo B, Tarantino A, Loglisci G, Matera R, Seripa D, Maffia M, Di Renzo N.   +8 more
europepmc   +1 more source

Topics of Interest in Women With Myeloproliferative Neoplasms. [PDF]

Am J Hematol
Szuber N, Guglielmelli P, Gangat N.
europepmc   +1 more source

CALR frameshift mutation detection in myeloproliferative neoplasms by microfluidic chip analysis. [PDF]

Lab Med
Greenwood MP, Newton KM, Pepper KL, Hendrickson HL, Olsen RJ, Thomas JS.   +5 more
europepmc   +1 more source

Trombose Venosa Esplâncnica: Factores de Risco [PDF]

, 2012
Tiago Alexandre Espada Guerreiro
core